Outcome measurement instruments for erythema associated with incontinence-associated dermatitis: Systematic review

J Adv Nurs. 2019 Nov;75(11):2393-2417. doi: 10.1111/jan.14102. Epub 2019 Jul 30.


Aim: To: (a) examine which outcome measurement instruments for erythema associated with incontinence-associated dermatitis (IAD) with supporting evidence about measurement properties are available; (b) evaluate the methodological quality of the studies and the quality of the measurement properties; and (c) identify eligible instruments to measure erythema in incontinence-associated dermatitis research.

Design: Systematic review.

Data sources: MEDLINE, EMBASE, CINAHL and CENTRAL were systematically searched until July 2018 (update December 2018). Additional input was gathered from 151 incontinence-associated dermatitis experts. Cited and citing references of included studies were screened.

Review methods: The COSMIN Risk of Bias checklist was applied to evaluate the methodological quality of the studies. Reported measurement properties were rated against criteria for good measurement properties.

Results: Fourteen studies, describing 10 measurement instruments, were included. In five instruments, erythema was captured as a separate concept, two studies provided empirical evidence about the measurement properties. The most studied measurement properties were reliability (9 studies), measurement error (4 studies) and criterion validity (4 studies). In one study, internal consistency was examined.

Conclusion: No instrument measuring exclusively erythema associated with incontinence-associated dermatitis exists. There is no single composite incontinence-associated dermatitis measurement instrument that outperforms others. Development or adaption of an instrument to measure erythema associated with incontinence-associated dermatitis is one option to solve this challenge.

Impact: The evidence about measurement properties of instruments measuring erythema associated with incontinence-associated dermatitis has not been summarized to date. The lack of an instrument should trigger activities to measure this domain accurately in future clinical trials.

目的: 在于:(a)检查与失禁性皮炎(简称为IAD)类红斑结果测量仪器以及测量属性有力证据的可用性;(b)评估研究的方法学质量和测量属性的质量;和(c)在失禁性皮炎研究中确定测量红斑的合格仪器。 设计: 系统综述。 资料来源: 在2018年7月(2018年12月更新)之前,系统性地搜索了MEDLINE、EMBASE、CINAHL和CENTRAL。从151名失禁性皮炎专家那里收集了其他信息。筛选了纳入研究的以往引用文献和现有引用文献。 综述方法: 使用了COSMIN 偏倚风险检查清单来评估研究的方法学质量。根据良好测量属性准则评级了报告的测量属性。 结果: 纳入了14项描述10种测量仪器的研究。在五种仪器中,捕获了作为单独理念的红斑,两项研究提供了关于测量属性的实验性证据。投入大多数研究的测量属性是信度(9项研究)、测量误差(4项研究)和标准效度(4项研究)。在一项研究中,检查了内部一致性。 结论: 不存在专门用来测量失禁性皮炎类红斑的仪器。没有单一的复合失禁性皮炎测量仪器比其他仪器还要好。开发或改造测量失禁性皮炎类红斑的仪器是解决这一挑战的选择之一。 影响: 迄今为止,尚未总结关于测量失禁性皮炎类红斑的仪器测量属性的证据。在未来的临床试验中,如果缺少一种仪器,则会开始准确测量该领域。.

Keywords: core outcome set; dermatology; erythema; incontinence-associated dermatitis; irritant contact dermatitis; literature review; measurement properties; nursing; outcome measurement instruments; systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Dermatitis / complications
  • Dermatitis / etiology*
  • Erythema / etiology*
  • Erythema / pathology
  • Fecal Incontinence / complications*
  • Humans
  • Outcome Assessment, Health Care*
  • Severity of Illness Index
  • Urinary Incontinence / complications*

Grant support